Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2001 Jan;70(1):9–14. doi: 10.1136/jnnp.70.1.9

Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study

F-E de Leeuw 1, J C de Groot 1, E Achten 1, M Oudkerk 1, L Ramos 1, R Heijboer 1, A Hofman 1, J Jolles 1, J van Gijn 1, M Breteler 1
PMCID: PMC1763449  PMID: 11118240

Abstract

OBJECTIVE—White matter lesions are often seen on MR scans of elderly non-demented and demented people. They are attributed to degenerative changes of small vessels and are implicated in the pathogenesis of cognitive decline and dementia. There is evidence that especially periventricular white matter lesions are related to cognitive decline, whereas subcortical white matter lesions may be related to late onset depression. The frequency distribution of subcortical and periventricular white matter lesions according to age and sex reported.
METHODS—A total of 1077 subjects aged between 60-90 years were randomly sampled from the general population. All subjects underwent 1.5T MR scanning; white matter lesions were rated separately for the subcortical region and the periventricular region.
RESULTS—Of all subjects 8% were completely free of subcortical white matter lesions, 20% had no periventricular white matter lesions, and 5% had no white matter lesions in either of these locations. The proportion with white matter lesions increased with age, similarly for men and women. Women tended to have more subcortical white matter lesions than men (total volume 1.45 ml v 1.29 ml; p=0.33), mainly caused by marked differences in the frontal white matter lesion volume (0.89 ml v 0.70 ml; p=0.08). Periventricular white matter lesions were also more frequent among women than men (mean grade 2.5 v 2.3; p=0.07). Also severe degrees of subcortical white matter lesions were more common in women than in men (OR 1.1; 95% confidence interval (95% CI) 0.8-1.5) and periventricular white matter lesions (OR 1.2; 95% CI 0.9-1.7), albeit that none of these findings were statistically significant.
CONCLUSIONS—The prevalence and the degree of cerebral white matter lesions increased with age. Women tended to have a higher degree of white matter lesions than men. This may underlie the finding of a higher incidence of dementia in women than in men, particularly at later age.



Full Text

The Full Text of this article is available as a PDF (148.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almkvist O., Wahlund L. O., Andersson-Lundman G., Basun H., Bäckman L. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol. 1992 Jun;49(6):626–632. doi: 10.1001/archneur.1992.00530300062011. [DOI] [PubMed] [Google Scholar]
  2. Bakker S. L., de Leeuw F. E., de Groot J. C., Hofman A., Koudstaal P. J., Breteler M. M. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology. 1999 Feb;52(3):578–583. doi: 10.1212/wnl.52.3.578. [DOI] [PubMed] [Google Scholar]
  3. Behl C., Davis J. B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 1994 Jun 17;77(6):817–827. doi: 10.1016/0092-8674(94)90131-7. [DOI] [PubMed] [Google Scholar]
  4. Breteler M. M., van Swieten J. C., Bots M. L., Grobbee D. E., Claus J. J., van den Hout J. H., van Harskamp F., Tanghe H. L., de Jong P. T., van Gijn J. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994 Jul;44(7):1246–1252. doi: 10.1212/wnl.44.7.1246. [DOI] [PubMed] [Google Scholar]
  5. Burns A., Murphy D. Protection against Alzheimer's disease? Lancet. 1996 Aug 17;348(9025):420–421. doi: 10.1016/S0140-6736(05)64533-3. [DOI] [PubMed] [Google Scholar]
  6. Erkinjuntti T., Ketonen L., Sulkava R., Sipponen J., Vuorialho M., Iivanainen M. Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry. 1987 Jan;50(1):37–42. doi: 10.1136/jnnp.50.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Goodman Y., Bruce A. J., Cheng B., Mattson M. P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem. 1996 May;66(5):1836–1844. doi: 10.1046/j.1471-4159.1996.66051836.x. [DOI] [PubMed] [Google Scholar]
  8. Hofman A., Boomsma F., Schalekamp M. A., Valkenburg H. A. Raised blood pressure and plasma noradrenaline concentrations in teenagers and young adults selected from an open population. Br Med J. 1979 Jun 9;1(6177):1536–1538. doi: 10.1136/bmj.1.6177.1536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hofman A., Grobbee D. E., de Jong P. T., van den Ouweland F. A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991 Jul;7(4):403–422. doi: 10.1007/BF00145007. [DOI] [PubMed] [Google Scholar]
  10. Katzman R., Aronson M., Fuld P., Kawas C., Brown T., Morgenstern H., Frishman W., Gidez L., Eder H., Ooi W. L. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol. 1989 Apr;25(4):317–324. doi: 10.1002/ana.410250402. [DOI] [PubMed] [Google Scholar]
  11. Kozachuk W. E., DeCarli C., Schapiro M. B., Wagner E. E., Rapoport S. I., Horwitz B. White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study. Arch Neurol. 1990 Dec;47(12):1306–1310. doi: 10.1001/archneur.1990.00530120050009. [DOI] [PubMed] [Google Scholar]
  12. Liao D., Cooper L., Cai J., Toole J. F., Bryan N. R., Hutchinson R. G., Tyroler H. A. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke. 1996 Dec;27(12):2262–2270. doi: 10.1161/01.str.27.12.2262. [DOI] [PubMed] [Google Scholar]
  13. Lindgren A., Roijer A., Rudling O., Norrving B., Larsson E. M., Eskilsson J., Wallin L., Olsson B., Johansson B. B. Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. A population-based study. Stroke. 1994 May;25(5):929–934. doi: 10.1161/01.str.25.5.929. [DOI] [PubMed] [Google Scholar]
  14. Longstreth W. T., Jr, Manolio T. A., Arnold A., Burke G. L., Bryan N., Jungreis C. A., Enright P. L., O'Leary D., Fried L. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996 Aug;27(8):1274–1282. doi: 10.1161/01.str.27.8.1274. [DOI] [PubMed] [Google Scholar]
  15. McEwen B. S., Alves S. E., Bulloch K., Weiland N. G. Ovarian steroids and the brain: implications for cognition and aging. Neurology. 1997 May;48(5 Suppl 7):S8–15. doi: 10.1212/wnl.48.5_suppl_7.8s. [DOI] [PubMed] [Google Scholar]
  16. Mooradian A. D. Antioxidant properties of steroids. J Steroid Biochem Mol Biol. 1993 Jun;45(6):509–511. doi: 10.1016/0960-0760(93)90166-t. [DOI] [PubMed] [Google Scholar]
  17. Mukai K., Daifuku K., Yokoyama S., Nakano M. Stopped-flow investigation of antioxidant activity of estrogens in solution. Biochim Biophys Acta. 1990 Sep 14;1035(3):348–352. doi: 10.1016/0304-4165(90)90099-i. [DOI] [PubMed] [Google Scholar]
  18. Niki E., Nakano M. Estrogens as antioxidants. Methods Enzymol. 1990;186:330–333. doi: 10.1016/0076-6879(90)86126-g. [DOI] [PubMed] [Google Scholar]
  19. O'Brien J. T., Ames D. White matter lesions in depression and Alzheimer's disease. Br J Psychiatry. 1996 Nov;169(5):671–671. doi: 10.1192/bjp.169.5.671a. [DOI] [PubMed] [Google Scholar]
  20. Ott A., Breteler M. M., van Harskamp F., Stijnen T., Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol. 1998 Mar 15;147(6):574–580. doi: 10.1093/oxfordjournals.aje.a009489. [DOI] [PubMed] [Google Scholar]
  21. Pantoni L., Garcia J. H. Pathogenesis of leukoaraiosis: a review. Stroke. 1997 Mar;28(3):652–659. doi: 10.1161/01.str.28.3.652. [DOI] [PubMed] [Google Scholar]
  22. Payami H., Zareparsi S., Montee K. R., Sexton G. J., Kaye J. A., Bird T. D., Yu C. E., Wijsman E. M., Heston L. L., Litt M. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet. 1996 Apr;58(4):803–811. [PMC free article] [PubMed] [Google Scholar]
  23. Sagara Y., Dargusch R., Klier F. G., Schubert D., Behl C. Increased antioxidant enzyme activity in amyloid beta protein-resistant cells. J Neurosci. 1996 Jan 15;16(2):497–505. doi: 10.1523/JNEUROSCI.16-02-00497.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schechter D. C. St. Vitus' dance and rheumatic disease. N Y State J Med. 1975 Jun;75(7):1091–1102. [PubMed] [Google Scholar]
  25. Scheltens P., Barkhof F., Valk J., Algra P. R., van der Hoop R. G., Nauta J., Wolters E. C. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain. 1992 Jun;115(Pt 3):735–748. doi: 10.1093/brain/115.3.735. [DOI] [PubMed] [Google Scholar]
  26. Schmidt R., Fazekas F., Kleinert G., Offenbacher H., Gindl K., Payer F., Freidl W., Niederkorn K., Lechner H. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch Neurol. 1992 Aug;49(8):825–827. doi: 10.1001/archneur.1992.00530320049011. [DOI] [PubMed] [Google Scholar]
  27. Schmidt R., Fazekas F., Offenbacher H., Dusek T., Zach E., Reinhart B., Grieshofer P., Freidl W., Eber B., Schumacher M. Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology. 1993 Dec;43(12):2490–2494. doi: 10.1212/wnl.43.12.2490. [DOI] [PubMed] [Google Scholar]
  28. Sijens P. E., Oudkerk M., de Leeuw F. E., de Groot J. C., Achten E., Heijboer R., Hofman A., Breteler M. M. 1H chemical shift imaging of the human brain at age 60-90 years reveals metabolic differences between women and men. Magn Reson Med. 1999 Jul;42(1):24–31. doi: 10.1002/(sici)1522-2594(199907)42:1<24::aid-mrm5>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  29. Ylikoski A., Erkinjuntti T., Raininko R., Sarna S., Sulkava R., Tilvis R. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke. 1995 Jul;26(7):1171–1177. doi: 10.1161/01.str.26.7.1171. [DOI] [PubMed] [Google Scholar]
  30. de Groot J. C., de Leeuw F. E., Breteler M. M. Cognitive correlates of cerebral white matter changes. J Neural Transm Suppl. 1998;53:41–67. doi: 10.1007/978-3-7091-6467-9_5. [DOI] [PubMed] [Google Scholar]
  31. de Groot J. C., de Leeuw F. E., Oudkerk M., van Gijn J., Hofman A., Jolles J., Breteler M. M. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol. 2000 Feb;47(2):145–151. doi: 10.1002/1531-8249(200002)47:2<145::aid-ana3>3.3.co;2-g. [DOI] [PubMed] [Google Scholar]
  32. de Leeuw F. E., de Groot J. C., Oudkerk M., Witteman J. C., Hofman A., van Gijn J., Breteler M. M. A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol. 1999 Dec;46(6):827–833. doi: 10.1002/1531-8249(199912)46:6<827::aid-ana4>3.3.co;2-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES